PubMed Mentions documentation

Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts. posted by NITRC Moderator on Dec 14

PubMed Mentions documentation

Assessing in-session rumination during CBT for depression: Replication and further evaluation of an observational measure. posted by NITRC Moderator on Nov 16

PubMed Mentions documentation

Using the 'Leapfrog' Design as a Simple Form of Adaptive Platform Trial to Develop, Test, and Implement Treatment Personalization Methods in Routine Practice. posted by NITRC Moderator on Oct 12

PubMed Mentions documentation

A Toolkit for Delirium Identification and Promoting Partnerships Between Carers and Nurses: A Pilot Pre-Post Feasibility Study. posted by NITRC Moderator on Sep 14

PubMed Mentions documentation

Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2. posted by NITRC Moderator on Sep 14

PubMed Mentions documentation

Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocol. posted by NITRC Moderator on Sep 14

PubMed Mentions documentation

Experiences of pediatric cancer patients (age 12-18 years) with extensive germline sequencing for cancer predisposition: a qualitative study. posted by NITRC Moderator on May 11

PubMed Mentions documentation

Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder. posted by NITRC Moderator on May 11

PubMed Mentions documentation

Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study. posted by NITRC Moderator on Apr 13

PubMed Mentions documentation

Developing questions to assess and measure patients' perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study. posted by NITRC Moderator on Mar 16

open-discussion forum

Welcome to Open-Discussion posted by Nina Preuss on Jun 27, 2017